
Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
CNN
A two-dose version of Johnson & Johnson's coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday -- making a two-dose regimen of J&J's Janssen vaccine comparable to a two-dose regimen of Moderna's or Pfizer's.
Plus, the company said, adding a booster dose to a single shot of the vaccine raised immunity even more, and should also protect people strongly against infection.
The company released some details of three studies looking at various aspects of its Janssen vaccine, and said that, taken together, they showed the vaccine provided long-lasting protection that could be boosted with an extra shot.

A number of Jeffrey Epstein survivors voiced their concern in a private meeting with female Democratic lawmakers earlier this week about the intermittent disclosure of Epstein-related documents and photos by Democrats on the House Oversight Committee, sharing that the selective publication of materials was distressing, four sources familiar with the call told CNN.












